nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—SLC22A2—Vinblastine—kidney cancer	0.0711	0.459	CbGbCtD
Memantine—CYP2B6—Sorafenib—kidney cancer	0.0374	0.241	CbGbCtD
Memantine—CYP2C19—Sorafenib—kidney cancer	0.0237	0.153	CbGbCtD
Memantine—CYP2B6—Doxorubicin—kidney cancer	0.0227	0.146	CbGbCtD
Memantine—SLC22A2—nephron—kidney cancer	0.00725	0.392	CbGeAlD
Memantine—CYP2C19—urine—kidney cancer	0.00317	0.171	CbGeAlD
Memantine—SLC22A2—nephron tubule—kidney cancer	0.00157	0.0845	CbGeAlD
Memantine—SLC22A2—renal system—kidney cancer	0.00142	0.0768	CbGeAlD
Memantine—SLC22A2—kidney—kidney cancer	0.00138	0.0743	CbGeAlD
Memantine—SLC22A2—cortex of kidney—kidney cancer	0.00134	0.0723	CbGeAlD
Memantine—CYP2B6—nephron tubule—kidney cancer	0.000668	0.036	CbGeAlD
Memantine—CYP2B6—renal system—kidney cancer	0.000607	0.0328	CbGeAlD
Memantine—CYP2B6—kidney—kidney cancer	0.000587	0.0317	CbGeAlD
Memantine—CYP2B6—gonad—kidney cancer	0.000544	0.0294	CbGeAlD
Memantine—Abdominal pain—Vincristine—kidney cancer	0.00014	0.000205	CcSEcCtD
Memantine—Body temperature increased—Vincristine—kidney cancer	0.00014	0.000205	CcSEcCtD
Memantine—Liver function test abnormal—Doxorubicin—kidney cancer	0.00014	0.000205	CcSEcCtD
Memantine—Infection—Paclitaxel—kidney cancer	0.00014	0.000205	CcSEcCtD
Memantine—Flatulence—Capecitabine—kidney cancer	0.00014	0.000204	CcSEcCtD
Memantine—Dry skin—Doxorubicin—kidney cancer	0.000139	0.000203	CcSEcCtD
Memantine—Dysgeusia—Capecitabine—kidney cancer	0.000139	0.000203	CcSEcCtD
Memantine—Dizziness—Sunitinib—kidney cancer	0.000139	0.000203	CcSEcCtD
Memantine—Feeling abnormal—Gemcitabine—kidney cancer	0.000139	0.000203	CcSEcCtD
Memantine—Shock—Paclitaxel—kidney cancer	0.000139	0.000203	CcSEcCtD
Memantine—Vomiting—Sorafenib—kidney cancer	0.000139	0.000203	CcSEcCtD
Memantine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000139	0.000202	CcSEcCtD
Memantine—Nervous system disorder—Paclitaxel—kidney cancer	0.000138	0.000202	CcSEcCtD
Memantine—Hypokalaemia—Doxorubicin—kidney cancer	0.000138	0.000202	CcSEcCtD
Memantine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000138	0.000202	CcSEcCtD
Memantine—Tachycardia—Paclitaxel—kidney cancer	0.000138	0.000201	CcSEcCtD
Memantine—Rash—Sorafenib—kidney cancer	0.000138	0.000201	CcSEcCtD
Memantine—Dermatitis—Sorafenib—kidney cancer	0.000138	0.000201	CcSEcCtD
Memantine—Back pain—Capecitabine—kidney cancer	0.000137	0.0002	CcSEcCtD
Memantine—Skin disorder—Paclitaxel—kidney cancer	0.000137	0.0002	CcSEcCtD
Memantine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000137	0.0002	CcSEcCtD
Memantine—Headache—Sorafenib—kidney cancer	0.000137	0.0002	CcSEcCtD
Memantine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000136	0.000199	CcSEcCtD
Memantine—Diarrhoea—Dactinomycin—kidney cancer	0.000136	0.000199	CcSEcCtD
Memantine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000136	0.000198	CcSEcCtD
Memantine—Anorexia—Paclitaxel—kidney cancer	0.000135	0.000196	CcSEcCtD
Memantine—Gastritis—Doxorubicin—kidney cancer	0.000134	0.000196	CcSEcCtD
Memantine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000134	0.000196	CcSEcCtD
Memantine—Muscular weakness—Doxorubicin—kidney cancer	0.000134	0.000196	CcSEcCtD
Memantine—Vision blurred—Capecitabine—kidney cancer	0.000134	0.000195	CcSEcCtD
Memantine—Vomiting—Sunitinib—kidney cancer	0.000134	0.000195	CcSEcCtD
Memantine—Body temperature increased—Gemcitabine—kidney cancer	0.000133	0.000194	CcSEcCtD
Memantine—Tremor—Capecitabine—kidney cancer	0.000133	0.000194	CcSEcCtD
Memantine—Rash—Sunitinib—kidney cancer	0.000132	0.000193	CcSEcCtD
Memantine—Dermatitis—Sunitinib—kidney cancer	0.000132	0.000193	CcSEcCtD
Memantine—Hypotension—Paclitaxel—kidney cancer	0.000132	0.000192	CcSEcCtD
Memantine—Ill-defined disorder—Capecitabine—kidney cancer	0.000132	0.000192	CcSEcCtD
Memantine—Headache—Sunitinib—kidney cancer	0.000132	0.000192	CcSEcCtD
Memantine—Influenza—Doxorubicin—kidney cancer	0.000131	0.000192	CcSEcCtD
Memantine—Dysphagia—Doxorubicin—kidney cancer	0.000131	0.000192	CcSEcCtD
Memantine—Asthma—Doxorubicin—kidney cancer	0.000131	0.000192	CcSEcCtD
Memantine—Anaemia—Capecitabine—kidney cancer	0.000131	0.000191	CcSEcCtD
Memantine—Hypersensitivity—Vincristine—kidney cancer	0.000131	0.000191	CcSEcCtD
Memantine—Nausea—Sorafenib—kidney cancer	0.00013	0.000189	CcSEcCtD
Memantine—Pancreatitis—Doxorubicin—kidney cancer	0.000129	0.000188	CcSEcCtD
Memantine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000129	0.000188	CcSEcCtD
Memantine—Malaise—Capecitabine—kidney cancer	0.000128	0.000187	CcSEcCtD
Memantine—Angina pectoris—Doxorubicin—kidney cancer	0.000128	0.000187	CcSEcCtD
Memantine—Insomnia—Paclitaxel—kidney cancer	0.000128	0.000186	CcSEcCtD
Memantine—Vertigo—Capecitabine—kidney cancer	0.000127	0.000186	CcSEcCtD
Memantine—Asthenia—Vincristine—kidney cancer	0.000127	0.000186	CcSEcCtD
Memantine—Syncope—Capecitabine—kidney cancer	0.000127	0.000186	CcSEcCtD
Memantine—Leukopenia—Capecitabine—kidney cancer	0.000127	0.000185	CcSEcCtD
Memantine—Paraesthesia—Paclitaxel—kidney cancer	0.000127	0.000185	CcSEcCtD
Memantine—Vomiting—Dactinomycin—kidney cancer	0.000126	0.000185	CcSEcCtD
Memantine—Bronchitis—Doxorubicin—kidney cancer	0.000126	0.000184	CcSEcCtD
Memantine—Dyspnoea—Paclitaxel—kidney cancer	0.000126	0.000184	CcSEcCtD
Memantine—Somnolence—Paclitaxel—kidney cancer	0.000125	0.000183	CcSEcCtD
Memantine—Palpitations—Capecitabine—kidney cancer	0.000125	0.000183	CcSEcCtD
Memantine—Rash—Dactinomycin—kidney cancer	0.000125	0.000183	CcSEcCtD
Memantine—Nausea—Sunitinib—kidney cancer	0.000125	0.000182	CcSEcCtD
Memantine—Loss of consciousness—Capecitabine—kidney cancer	0.000125	0.000182	CcSEcCtD
Memantine—Pancytopenia—Doxorubicin—kidney cancer	0.000125	0.000182	CcSEcCtD
Memantine—Dyspepsia—Paclitaxel—kidney cancer	0.000124	0.000181	CcSEcCtD
Memantine—Cough—Capecitabine—kidney cancer	0.000124	0.000181	CcSEcCtD
Memantine—Neutropenia—Doxorubicin—kidney cancer	0.000123	0.000179	CcSEcCtD
Memantine—Dysuria—Doxorubicin—kidney cancer	0.000123	0.000179	CcSEcCtD
Memantine—Decreased appetite—Paclitaxel—kidney cancer	0.000123	0.000179	CcSEcCtD
Memantine—Hypertension—Capecitabine—kidney cancer	0.000123	0.000179	CcSEcCtD
Memantine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000122	0.000178	CcSEcCtD
Memantine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000122	0.000178	CcSEcCtD
Memantine—Fatigue—Paclitaxel—kidney cancer	0.000122	0.000178	CcSEcCtD
Memantine—Diarrhoea—Vincristine—kidney cancer	0.000122	0.000177	CcSEcCtD
Memantine—Pollakiuria—Doxorubicin—kidney cancer	0.000121	0.000177	CcSEcCtD
Memantine—Asthenia—Gemcitabine—kidney cancer	0.000121	0.000177	CcSEcCtD
Memantine—Myalgia—Capecitabine—kidney cancer	0.000121	0.000176	CcSEcCtD
Memantine—Arthralgia—Capecitabine—kidney cancer	0.000121	0.000176	CcSEcCtD
Memantine—Chest pain—Capecitabine—kidney cancer	0.000121	0.000176	CcSEcCtD
Memantine—Pain—Paclitaxel—kidney cancer	0.000121	0.000176	CcSEcCtD
Memantine—Constipation—Paclitaxel—kidney cancer	0.000121	0.000176	CcSEcCtD
Memantine—Anxiety—Capecitabine—kidney cancer	0.00012	0.000176	CcSEcCtD
Memantine—Weight increased—Doxorubicin—kidney cancer	0.000119	0.000174	CcSEcCtD
Memantine—Discomfort—Capecitabine—kidney cancer	0.000119	0.000174	CcSEcCtD
Memantine—Pruritus—Gemcitabine—kidney cancer	0.000119	0.000174	CcSEcCtD
Memantine—Weight decreased—Doxorubicin—kidney cancer	0.000119	0.000173	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—kidney cancer	0.000118	0.000173	CcSEcCtD
Memantine—Dry mouth—Capecitabine—kidney cancer	0.000118	0.000172	CcSEcCtD
Memantine—Nausea—Dactinomycin—kidney cancer	0.000118	0.000172	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—kidney cancer	0.000118	0.000172	CcSEcCtD
Memantine—Dizziness—Vincristine—kidney cancer	0.000117	0.000171	CcSEcCtD
Memantine—Infestation—Doxorubicin—kidney cancer	0.000117	0.000171	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—kidney cancer	0.000117	0.000171	CcSEcCtD
Memantine—Confusional state—Capecitabine—kidney cancer	0.000117	0.00017	CcSEcCtD
Memantine—Feeling abnormal—Paclitaxel—kidney cancer	0.000116	0.00017	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000116	0.000169	CcSEcCtD
Memantine—Oedema—Capecitabine—kidney cancer	0.000116	0.000169	CcSEcCtD
Memantine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000115	0.000168	CcSEcCtD
Memantine—Diarrhoea—Gemcitabine—kidney cancer	0.000115	0.000168	CcSEcCtD
Memantine—Renal failure—Doxorubicin—kidney cancer	0.000115	0.000168	CcSEcCtD
Memantine—Infection—Capecitabine—kidney cancer	0.000115	0.000168	CcSEcCtD
Memantine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000115	0.000167	CcSEcCtD
Memantine—Shock—Capecitabine—kidney cancer	0.000114	0.000166	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—kidney cancer	0.000114	0.000166	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—kidney cancer	0.000114	0.000166	CcSEcCtD
Memantine—Nervous system disorder—Capecitabine—kidney cancer	0.000114	0.000166	CcSEcCtD
Memantine—Thrombocytopenia—Capecitabine—kidney cancer	0.000113	0.000165	CcSEcCtD
Memantine—Tachycardia—Capecitabine—kidney cancer	0.000113	0.000165	CcSEcCtD
Memantine—Vomiting—Vincristine—kidney cancer	0.000113	0.000165	CcSEcCtD
Memantine—Skin disorder—Capecitabine—kidney cancer	0.000112	0.000164	CcSEcCtD
Memantine—Urticaria—Paclitaxel—kidney cancer	0.000112	0.000164	CcSEcCtD
Memantine—Rash—Vincristine—kidney cancer	0.000112	0.000164	CcSEcCtD
Memantine—Hyperhidrosis—Capecitabine—kidney cancer	0.000112	0.000163	CcSEcCtD
Memantine—Dermatitis—Vincristine—kidney cancer	0.000112	0.000163	CcSEcCtD
Memantine—Haematuria—Doxorubicin—kidney cancer	0.000112	0.000163	CcSEcCtD
Memantine—Abdominal pain—Paclitaxel—kidney cancer	0.000112	0.000163	CcSEcCtD
Memantine—Body temperature increased—Paclitaxel—kidney cancer	0.000112	0.000163	CcSEcCtD
Memantine—Headache—Vincristine—kidney cancer	0.000111	0.000162	CcSEcCtD
Memantine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000111	0.000162	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—kidney cancer	0.00011	0.000161	CcSEcCtD
Memantine—Anorexia—Capecitabine—kidney cancer	0.00011	0.000161	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—kidney cancer	0.00011	0.00016	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—kidney cancer	0.000109	0.000159	CcSEcCtD
Memantine—Hypotension—Capecitabine—kidney cancer	0.000108	0.000158	CcSEcCtD
Memantine—Vomiting—Gemcitabine—kidney cancer	0.000107	0.000156	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—kidney cancer	0.000107	0.000156	CcSEcCtD
Memantine—Rash—Gemcitabine—kidney cancer	0.000106	0.000155	CcSEcCtD
Memantine—Dermatitis—Gemcitabine—kidney cancer	0.000106	0.000155	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—kidney cancer	0.000106	0.000154	CcSEcCtD
Memantine—Headache—Gemcitabine—kidney cancer	0.000106	0.000154	CcSEcCtD
Memantine—Nausea—Vincristine—kidney cancer	0.000106	0.000154	CcSEcCtD
Memantine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000106	0.000154	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—kidney cancer	0.000105	0.000154	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—kidney cancer	0.000105	0.000153	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—kidney cancer	0.000105	0.000153	CcSEcCtD
Memantine—Insomnia—Capecitabine—kidney cancer	0.000105	0.000153	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000105	0.000153	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—kidney cancer	0.000104	0.000152	CcSEcCtD
Memantine—Paraesthesia—Capecitabine—kidney cancer	0.000104	0.000152	CcSEcCtD
Memantine—Hypersensitivity—Paclitaxel—kidney cancer	0.000104	0.000152	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—kidney cancer	0.000104	0.000151	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—kidney cancer	0.000104	0.000151	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—kidney cancer	0.000103	0.000151	CcSEcCtD
Memantine—Dyspnoea—Capecitabine—kidney cancer	0.000103	0.000151	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—kidney cancer	0.000103	0.00015	CcSEcCtD
Memantine—Dyspepsia—Capecitabine—kidney cancer	0.000102	0.000149	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—kidney cancer	0.000101	0.000148	CcSEcCtD
Memantine—Asthenia—Paclitaxel—kidney cancer	0.000101	0.000148	CcSEcCtD
Memantine—Decreased appetite—Capecitabine—kidney cancer	0.000101	0.000147	CcSEcCtD
Memantine—Nausea—Gemcitabine—kidney cancer	0.0001	0.000146	CcSEcCtD
Memantine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.0001	0.000146	CcSEcCtD
Memantine—Fatigue—Capecitabine—kidney cancer	9.98e-05	0.000146	CcSEcCtD
Memantine—Pruritus—Paclitaxel—kidney cancer	9.98e-05	0.000146	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—kidney cancer	9.93e-05	0.000145	CcSEcCtD
Memantine—Pain—Capecitabine—kidney cancer	9.9e-05	0.000145	CcSEcCtD
Memantine—Constipation—Capecitabine—kidney cancer	9.9e-05	0.000145	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—kidney cancer	9.82e-05	0.000143	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—kidney cancer	9.8e-05	0.000143	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—kidney cancer	9.75e-05	0.000142	CcSEcCtD
Memantine—Flushing—Doxorubicin—kidney cancer	9.75e-05	0.000142	CcSEcCtD
Memantine—Diarrhoea—Paclitaxel—kidney cancer	9.65e-05	0.000141	CcSEcCtD
Memantine—Feeling abnormal—Capecitabine—kidney cancer	9.54e-05	0.000139	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—kidney cancer	9.53e-05	0.000139	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—ANXA1—kidney cancer	9.51e-05	0.000672	CbGpPWpGaD
Memantine—Immune system disorder—Doxorubicin—kidney cancer	9.49e-05	0.000139	CcSEcCtD
Memantine—GRIN2A—Neuronal System—MAPK1—kidney cancer	9.47e-05	0.000669	CbGpPWpGaD
Memantine—Gastrointestinal pain—Capecitabine—kidney cancer	9.47e-05	0.000138	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—kidney cancer	9.47e-05	0.000138	CcSEcCtD
Memantine—Chills—Doxorubicin—kidney cancer	9.43e-05	0.000138	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—kidney cancer	9.39e-05	0.000137	CcSEcCtD
Memantine—Dizziness—Paclitaxel—kidney cancer	9.33e-05	0.000136	CcSEcCtD
Memantine—Alopecia—Doxorubicin—kidney cancer	9.28e-05	0.000136	CcSEcCtD
Memantine—Mental disorder—Doxorubicin—kidney cancer	9.2e-05	0.000134	CcSEcCtD
Memantine—Urticaria—Capecitabine—kidney cancer	9.2e-05	0.000134	CcSEcCtD
Memantine—Body temperature increased—Capecitabine—kidney cancer	9.15e-05	0.000134	CcSEcCtD
Memantine—Abdominal pain—Capecitabine—kidney cancer	9.15e-05	0.000134	CcSEcCtD
Memantine—SLC22A2—Metabolism—GLIPR1—kidney cancer	9.15e-05	0.000646	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPAT—kidney cancer	9.15e-05	0.000646	CbGpPWpGaD
Memantine—Malnutrition—Doxorubicin—kidney cancer	9.15e-05	0.000134	CcSEcCtD
Memantine—Flatulence—Doxorubicin—kidney cancer	9.01e-05	0.000132	CcSEcCtD
Memantine—Tension—Doxorubicin—kidney cancer	8.98e-05	0.000131	CcSEcCtD
Memantine—Vomiting—Paclitaxel—kidney cancer	8.97e-05	0.000131	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—kidney cancer	8.96e-05	0.000131	CcSEcCtD
Memantine—Rash—Paclitaxel—kidney cancer	8.9e-05	0.00013	CcSEcCtD
Memantine—Dermatitis—Paclitaxel—kidney cancer	8.89e-05	0.00013	CcSEcCtD
Memantine—Nervousness—Doxorubicin—kidney cancer	8.88e-05	0.00013	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—GSTM1—kidney cancer	8.86e-05	0.000626	CbGpPWpGaD
Memantine—Back pain—Doxorubicin—kidney cancer	8.85e-05	0.000129	CcSEcCtD
Memantine—Headache—Paclitaxel—kidney cancer	8.84e-05	0.000129	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	8.74e-05	0.000617	CbGpPWpGaD
Memantine—Vision blurred—Doxorubicin—kidney cancer	8.62e-05	0.000126	CcSEcCtD
Memantine—Hypersensitivity—Capecitabine—kidney cancer	8.53e-05	0.000125	CcSEcCtD
Memantine—SLC22A2—Metabolism—FH—kidney cancer	8.5e-05	0.000601	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APRT—kidney cancer	8.5e-05	0.000601	CbGpPWpGaD
Memantine—Ill-defined disorder—Doxorubicin—kidney cancer	8.49e-05	0.000124	CcSEcCtD
Memantine—Anaemia—Doxorubicin—kidney cancer	8.45e-05	0.000123	CcSEcCtD
Memantine—Agitation—Doxorubicin—kidney cancer	8.41e-05	0.000123	CcSEcCtD
Memantine—CYP2A6—Metabolism—GLIPR1—kidney cancer	8.4e-05	0.000593	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPAT—kidney cancer	8.4e-05	0.000593	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	8.4e-05	0.000593	CbGpPWpGaD
Memantine—Nausea—Paclitaxel—kidney cancer	8.38e-05	0.000122	CcSEcCtD
Memantine—CYP2B6—Metabolism—PDHB—kidney cancer	8.31e-05	0.000587	CbGpPWpGaD
Memantine—Asthenia—Capecitabine—kidney cancer	8.31e-05	0.000121	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—POMC—kidney cancer	8.29e-05	0.000585	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	8.28e-05	0.000585	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LATS1—kidney cancer	8.28e-05	0.000585	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—MAPK1—kidney cancer	8.26e-05	0.000584	CbGpPWpGaD
Memantine—Malaise—Doxorubicin—kidney cancer	8.25e-05	0.00012	CcSEcCtD
Memantine—Vertigo—Doxorubicin—kidney cancer	8.22e-05	0.00012	CcSEcCtD
Memantine—Syncope—Doxorubicin—kidney cancer	8.2e-05	0.00012	CcSEcCtD
Memantine—Pruritus—Capecitabine—kidney cancer	8.19e-05	0.00012	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—kidney cancer	8.19e-05	0.000119	CcSEcCtD
Memantine—SLC22A2—Transmission across Chemical Synapses—RAF1—kidney cancer	8.18e-05	0.000578	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—kidney cancer	8.15e-05	0.000575	CbGpPWpGaD
Memantine—Palpitations—Doxorubicin—kidney cancer	8.08e-05	0.000118	CcSEcCtD
Memantine—GRIN2B—Neuronal System—MAPK1—kidney cancer	8.06e-05	0.000569	CbGpPWpGaD
Memantine—Loss of consciousness—Doxorubicin—kidney cancer	8.04e-05	0.000117	CcSEcCtD
Memantine—SLC22A2—Metabolism—GPC3—kidney cancer	8e-05	0.000565	CbGpPWpGaD
Memantine—Cough—Doxorubicin—kidney cancer	7.98e-05	0.000116	CcSEcCtD
Memantine—GRIN2B—Axon guidance—VEGFA—kidney cancer	7.94e-05	0.000561	CbGpPWpGaD
Memantine—Convulsion—Doxorubicin—kidney cancer	7.92e-05	0.000116	CcSEcCtD
Memantine—Diarrhoea—Capecitabine—kidney cancer	7.92e-05	0.000116	CcSEcCtD
Memantine—Hypertension—Doxorubicin—kidney cancer	7.9e-05	0.000115	CcSEcCtD
Memantine—CYP2B6—Metabolism—CCBL1—kidney cancer	7.81e-05	0.000552	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APRT—kidney cancer	7.81e-05	0.000552	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—FH—kidney cancer	7.81e-05	0.000552	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.81e-05	0.000552	CbGpPWpGaD
Memantine—Chest pain—Doxorubicin—kidney cancer	7.79e-05	0.000114	CcSEcCtD
Memantine—Myalgia—Doxorubicin—kidney cancer	7.79e-05	0.000114	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—kidney cancer	7.79e-05	0.000114	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—RAF1—kidney cancer	7.79e-05	0.00055	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CA2—kidney cancer	7.78e-05	0.00055	CbGpPWpGaD
Memantine—Anxiety—Doxorubicin—kidney cancer	7.76e-05	0.000113	CcSEcCtD
Memantine—GRIN1—Axon guidance—MAPK3—kidney cancer	7.71e-05	0.000544	CbGpPWpGaD
Memantine—Discomfort—Doxorubicin—kidney cancer	7.69e-05	0.000112	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—POMC—kidney cancer	7.69e-05	0.000543	CbGpPWpGaD
Memantine—Dizziness—Capecitabine—kidney cancer	7.66e-05	0.000112	CcSEcCtD
Memantine—GRIN1—Developmental Biology—RAF1—kidney cancer	7.63e-05	0.000539	CbGpPWpGaD
Memantine—Dry mouth—Doxorubicin—kidney cancer	7.62e-05	0.000111	CcSEcCtD
Memantine—GRIN1—Developmental Biology—RELA—kidney cancer	7.59e-05	0.000537	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALAD—kidney cancer	7.58e-05	0.000536	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ERBB2—kidney cancer	7.55e-05	0.000533	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.54e-05	0.000533	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKAP13—kidney cancer	7.54e-05	0.000533	CbGpPWpGaD
Memantine—Confusional state—Doxorubicin—kidney cancer	7.53e-05	0.00011	CcSEcCtD
Memantine—GRIN2B—Axon guidance—MAPK3—kidney cancer	7.51e-05	0.000531	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—BRAF—kidney cancer	7.5e-05	0.00053	CbGpPWpGaD
Memantine—Oedema—Doxorubicin—kidney cancer	7.46e-05	0.000109	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—RAF1—kidney cancer	7.44e-05	0.000525	CbGpPWpGaD
Memantine—Infection—Doxorubicin—kidney cancer	7.42e-05	0.000108	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—RELA—kidney cancer	7.4e-05	0.000523	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ST3GAL2—kidney cancer	7.4e-05	0.000523	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ACY1—kidney cancer	7.39e-05	0.000522	CbGpPWpGaD
Memantine—Vomiting—Capecitabine—kidney cancer	7.36e-05	0.000107	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—ERBB2—kidney cancer	7.36e-05	0.00052	CbGpPWpGaD
Memantine—Shock—Doxorubicin—kidney cancer	7.34e-05	0.000107	CcSEcCtD
Memantine—CYP2A6—Metabolism—GPC3—kidney cancer	7.34e-05	0.000519	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MAPK1—kidney cancer	7.33e-05	0.000518	CbGpPWpGaD
Memantine—Nervous system disorder—Doxorubicin—kidney cancer	7.32e-05	0.000107	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—kidney cancer	7.31e-05	0.000107	CcSEcCtD
Memantine—Rash—Capecitabine—kidney cancer	7.3e-05	0.000107	CcSEcCtD
Memantine—Dermatitis—Capecitabine—kidney cancer	7.29e-05	0.000106	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—kidney cancer	7.29e-05	0.000106	CcSEcCtD
Memantine—Headache—Capecitabine—kidney cancer	7.25e-05	0.000106	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—kidney cancer	7.25e-05	0.000106	CcSEcCtD
Memantine—SLC22A2—Metabolism—ALDH1A1—kidney cancer	7.23e-05	0.000511	CbGpPWpGaD
Memantine—Hyperhidrosis—Doxorubicin—kidney cancer	7.22e-05	0.000105	CcSEcCtD
Memantine—GRIN2B—Axon guidance—MAPK1—kidney cancer	7.15e-05	0.000505	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CA2—kidney cancer	7.14e-05	0.000504	CbGpPWpGaD
Memantine—Anorexia—Doxorubicin—kidney cancer	7.12e-05	0.000104	CcSEcCtD
Memantine—DRD2—Signaling Pathways—AMER1—kidney cancer	7.04e-05	0.000497	CbGpPWpGaD
Memantine—Hypotension—Doxorubicin—kidney cancer	6.98e-05	0.000102	CcSEcCtD
Memantine—CYP2A6—Metabolism—ALAD—kidney cancer	6.96e-05	0.000492	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PGK1—kidney cancer	6.93e-05	0.00049	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC5A3—kidney cancer	6.93e-05	0.00049	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—kidney cancer	6.93e-05	0.000489	CbGpPWpGaD
Memantine—Nausea—Capecitabine—kidney cancer	6.88e-05	0.0001	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—AKAP13—kidney cancer	6.85e-05	0.000484	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.8e-05	9.93e-05	CcSEcCtD
Memantine—SLC22A2—Metabolism—LDHB—kidney cancer	6.8e-05	0.00048	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ST3GAL2—kidney cancer	6.79e-05	0.00048	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPAT—kidney cancer	6.78e-05	0.000479	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GLIPR1—kidney cancer	6.78e-05	0.000479	CbGpPWpGaD
Memantine—Insomnia—Doxorubicin—kidney cancer	6.75e-05	9.85e-05	CcSEcCtD
Memantine—GRIN2B—Axon guidance—KRAS—kidney cancer	6.75e-05	0.000477	CbGpPWpGaD
Memantine—Paraesthesia—Doxorubicin—kidney cancer	6.7e-05	9.78e-05	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—kidney cancer	6.65e-05	9.71e-05	CcSEcCtD
Memantine—CYP2A6—Metabolism—ALDH1A1—kidney cancer	6.64e-05	0.000469	CbGpPWpGaD
Memantine—Somnolence—Doxorubicin—kidney cancer	6.64e-05	9.69e-05	CcSEcCtD
Memantine—GRIN1—Developmental Biology—CTNNB1—kidney cancer	6.6e-05	0.000466	CbGpPWpGaD
Memantine—Dyspepsia—Doxorubicin—kidney cancer	6.57e-05	9.59e-05	CcSEcCtD
Memantine—Decreased appetite—Doxorubicin—kidney cancer	6.49e-05	9.47e-05	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.44e-05	9.41e-05	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—CTNNB1—kidney cancer	6.44e-05	0.000455	CbGpPWpGaD
Memantine—Fatigue—Doxorubicin—kidney cancer	6.44e-05	9.39e-05	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—ITPR2—kidney cancer	6.41e-05	0.000453	CbGpPWpGaD
Memantine—Constipation—Doxorubicin—kidney cancer	6.38e-05	9.32e-05	CcSEcCtD
Memantine—Pain—Doxorubicin—kidney cancer	6.38e-05	9.32e-05	CcSEcCtD
Memantine—CYP2A6—Metabolism—SLC5A3—kidney cancer	6.36e-05	0.00045	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PGK1—kidney cancer	6.36e-05	0.00045	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.3e-05	0.000445	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APRT—kidney cancer	6.3e-05	0.000445	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—FH—kidney cancer	6.3e-05	0.000445	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PDHB—kidney cancer	6.28e-05	0.000444	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—JUN—kidney cancer	6.27e-05	0.000443	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—RAF1—kidney cancer	6.26e-05	0.000443	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—POMC—kidney cancer	6.26e-05	0.000442	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—LDHB—kidney cancer	6.24e-05	0.000441	CbGpPWpGaD
Memantine—Feeling abnormal—Doxorubicin—kidney cancer	6.15e-05	8.98e-05	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	6.12e-05	0.000432	CbGpPWpGaD
Memantine—Gastrointestinal pain—Doxorubicin—kidney cancer	6.1e-05	8.91e-05	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—PTEN—kidney cancer	6.06e-05	0.000428	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.95e-05	0.000421	CbGpPWpGaD
Memantine—Urticaria—Doxorubicin—kidney cancer	5.93e-05	8.66e-05	CcSEcCtD
Memantine—CYP2B6—Metabolism—GPC3—kidney cancer	5.92e-05	0.000418	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CCBL1—kidney cancer	5.91e-05	0.000417	CbGpPWpGaD
Memantine—Abdominal pain—Doxorubicin—kidney cancer	5.9e-05	8.61e-05	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—kidney cancer	5.9e-05	8.61e-05	CcSEcCtD
Memantine—DRD2—Signaling Pathways—GPC3—kidney cancer	5.9e-05	0.000417	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CER1—kidney cancer	5.9e-05	0.000417	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CA9—kidney cancer	5.89e-05	0.000416	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ITPR2—kidney cancer	5.82e-05	0.000411	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—kidney cancer	5.81e-05	0.000411	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CA2—kidney cancer	5.76e-05	0.000407	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—kidney cancer	5.67e-05	0.0004	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALAD—kidney cancer	5.61e-05	0.000397	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.61e-05	0.000396	CbGpPWpGaD
Memantine—Hypersensitivity—Doxorubicin—kidney cancer	5.5e-05	8.03e-05	CcSEcCtD
Memantine—GRIN1—Developmental Biology—MAPK3—kidney cancer	5.5e-05	0.000388	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ST3GAL2—kidney cancer	5.48e-05	0.000387	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CA9—kidney cancer	5.41e-05	0.000382	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ANXA1—kidney cancer	5.37e-05	0.000379	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MAPK3—kidney cancer	5.36e-05	0.000379	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALDH1A1—kidney cancer	5.36e-05	0.000378	CbGpPWpGaD
Memantine—Asthenia—Doxorubicin—kidney cancer	5.36e-05	7.82e-05	CcSEcCtD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.34e-05	0.000377	CbGpPWpGaD
Memantine—Pruritus—Doxorubicin—kidney cancer	5.28e-05	7.71e-05	CcSEcCtD
Memantine—GRIN1—Developmental Biology—MAPK1—kidney cancer	5.23e-05	0.00037	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PGK1—kidney cancer	5.14e-05	0.000363	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC5A3—kidney cancer	5.14e-05	0.000363	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GLIPR1—kidney cancer	5.12e-05	0.000362	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPAT—kidney cancer	5.12e-05	0.000362	CbGpPWpGaD
Memantine—Diarrhoea—Doxorubicin—kidney cancer	5.11e-05	7.45e-05	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—MAPK1—kidney cancer	5.1e-05	0.00036	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.06e-05	0.000357	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—LDHB—kidney cancer	5.04e-05	0.000356	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SFRP2—kidney cancer	5.02e-05	0.000354	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CRABP1—kidney cancer	5.01e-05	0.000354	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5e-05	0.000354	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—kidney cancer	4.94e-05	0.000349	CbGpPWpGaD
Memantine—Dizziness—Doxorubicin—kidney cancer	4.94e-05	7.2e-05	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—ANXA1—kidney cancer	4.88e-05	0.000345	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—kidney cancer	4.82e-05	0.00034	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—FH—kidney cancer	4.76e-05	0.000336	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APRT—kidney cancer	4.76e-05	0.000336	CbGpPWpGaD
Memantine—Vomiting—Doxorubicin—kidney cancer	4.75e-05	6.93e-05	CcSEcCtD
Memantine—Rash—Doxorubicin—kidney cancer	4.71e-05	6.87e-05	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—kidney cancer	4.7e-05	6.86e-05	CcSEcCtD
Memantine—Headache—Doxorubicin—kidney cancer	4.68e-05	6.83e-05	CcSEcCtD
Memantine—SLC22A2—Metabolism—ITPR2—kidney cancer	4.66e-05	0.000329	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—POMC—kidney cancer	4.66e-05	0.000329	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.65e-05	0.000329	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CRABP1—kidney cancer	4.6e-05	0.000325	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPC3—kidney cancer	4.48e-05	0.000316	CbGpPWpGaD
Memantine—Nausea—Doxorubicin—kidney cancer	4.43e-05	6.47e-05	CcSEcCtD
Memantine—CYP2B6—Metabolism—CA9—kidney cancer	4.37e-05	0.000308	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA2—kidney cancer	4.35e-05	0.000308	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—MAPK1—kidney cancer	4.3e-05	0.000304	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ITPR2—kidney cancer	4.28e-05	0.000302	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ACHE—kidney cancer	4.25e-05	0.0003	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTT1—kidney cancer	4.25e-05	0.0003	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALAD—kidney cancer	4.24e-05	0.0003	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	4.14e-05	0.000293	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—kidney cancer	4.14e-05	0.000292	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	4.05e-05	0.000286	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP2—kidney cancer	4.04e-05	0.000286	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKAP13—kidney cancer	4.04e-05	0.000286	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SCARB1—kidney cancer	4.02e-05	0.000284	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS1—kidney cancer	3.98e-05	0.000281	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PSMD7—kidney cancer	3.9e-05	0.000276	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTT1—kidney cancer	3.9e-05	0.000276	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ACHE—kidney cancer	3.9e-05	0.000276	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PGK1—kidney cancer	3.88e-05	0.000274	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC5A3—kidney cancer	3.88e-05	0.000274	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LDHB—kidney cancer	3.81e-05	0.000269	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CRABP1—kidney cancer	3.71e-05	0.000262	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BCHE—kidney cancer	3.7e-05	0.000262	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRB7—kidney cancer	3.7e-05	0.000261	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SCARB1—kidney cancer	3.69e-05	0.000261	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC5A5—kidney cancer	3.66e-05	0.000258	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS1—kidney cancer	3.66e-05	0.000258	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PSMD7—kidney cancer	3.58e-05	0.000253	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC2A1—kidney cancer	3.53e-05	0.000249	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ITPR2—kidney cancer	3.45e-05	0.000244	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ITPR2—kidney cancer	3.44e-05	0.000243	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BCHE—kidney cancer	3.4e-05	0.00024	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.37e-05	0.000238	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC5A5—kidney cancer	3.36e-05	0.000237	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA9—kidney cancer	3.3e-05	0.000233	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC2A1—kidney cancer	3.24e-05	0.000229	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.22e-05	0.000228	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ACHE—kidney cancer	3.15e-05	0.000222	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTT1—kidney cancer	3.15e-05	0.000222	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNA1—kidney cancer	3.12e-05	0.00022	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EIF4EBP1—kidney cancer	3.1e-05	0.000219	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HSPB1—kidney cancer	3.1e-05	0.000219	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SCARB1—kidney cancer	2.98e-05	0.00021	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS1—kidney cancer	2.95e-05	0.000208	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTP1—kidney cancer	2.95e-05	0.000208	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PSMD7—kidney cancer	2.89e-05	0.000204	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSMD7—kidney cancer	2.88e-05	0.000204	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSC1—kidney cancer	2.88e-05	0.000204	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ANXA1—kidney cancer	2.88e-05	0.000204	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CRABP1—kidney cancer	2.81e-05	0.000198	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FLT1—kidney cancer	2.79e-05	0.000197	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—kidney cancer	2.79e-05	0.000197	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BCHE—kidney cancer	2.74e-05	0.000194	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC5A5—kidney cancer	2.71e-05	0.000191	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—kidney cancer	2.71e-05	0.000191	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTP1—kidney cancer	2.7e-05	0.000191	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—POMC—kidney cancer	2.63e-05	0.000186	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.62e-05	0.000185	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ITPR2—kidney cancer	2.61e-05	0.000184	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JUNB—kidney cancer	2.59e-05	0.000183	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PAK1—kidney cancer	2.59e-05	0.000183	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1A1—kidney cancer	2.57e-05	0.000181	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—kidney cancer	2.56e-05	0.000181	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—kidney cancer	2.48e-05	0.000176	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.4e-05	0.00017	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—POMC—kidney cancer	2.39e-05	0.000169	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTT1—kidney cancer	2.38e-05	0.000168	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ACHE—kidney cancer	2.38e-05	0.000168	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1A1—kidney cancer	2.36e-05	0.000166	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SCARB1—kidney cancer	2.25e-05	0.000159	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS1—kidney cancer	2.23e-05	0.000157	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PSMD7—kidney cancer	2.19e-05	0.000154	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTP1—kidney cancer	2.18e-05	0.000154	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF2—kidney cancer	2.12e-05	0.000149	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN2B—kidney cancer	2.11e-05	0.000149	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BCHE—kidney cancer	2.07e-05	0.000146	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—kidney cancer	2.07e-05	0.000146	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.05e-05	0.000145	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1R—kidney cancer	2.04e-05	0.000144	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—kidney cancer	2e-05	0.000142	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.98e-05	0.00014	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RAF1—kidney cancer	1.97e-05	0.000139	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—kidney cancer	1.95e-05	0.000137	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.92e-05	0.000135	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—POMC—kidney cancer	1.91e-05	0.000135	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.9e-05	0.000134	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—kidney cancer	1.77e-05	0.000125	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—POMC—kidney cancer	1.76e-05	0.000124	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIF1A—kidney cancer	1.68e-05	0.000119	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSC2—kidney cancer	1.68e-05	0.000119	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.67e-05	0.000118	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTP1—kidney cancer	1.65e-05	0.000116	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—kidney cancer	1.61e-05	0.000114	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—kidney cancer	1.56e-05	0.00011	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—kidney cancer	1.53e-05	0.000108	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—kidney cancer	1.51e-05	0.000107	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KIT—kidney cancer	1.48e-05	0.000105	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APC—kidney cancer	1.48e-05	0.000105	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.44e-05	0.000101	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK3—kidney cancer	1.42e-05	0.0001	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—POMC—kidney cancer	1.42e-05	0.0001	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—POMC—kidney cancer	1.41e-05	9.97e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—kidney cancer	1.4e-05	9.9e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BRAF—kidney cancer	1.39e-05	9.85e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK1—kidney cancer	1.35e-05	9.55e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—kidney cancer	1.33e-05	9.4e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	1.29e-05	9.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—kidney cancer	1.28e-05	9.02e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—kidney cancer	1.22e-05	8.63e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.18e-05	8.34e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	1.17e-05	8.29e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAF1—kidney cancer	1.16e-05	8.22e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RELA—kidney cancer	1.16e-05	8.19e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—kidney cancer	1.15e-05	8.14e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MTOR—kidney cancer	1.14e-05	8.03e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—kidney cancer	1.13e-05	7.98e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—POMC—kidney cancer	1.07e-05	7.56e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	1.07e-05	7.53e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—kidney cancer	1.04e-05	7.37e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—kidney cancer	1.02e-05	7.19e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JUN—kidney cancer	1.02e-05	7.17e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	1.01e-05	7.12e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—kidney cancer	9.86e-06	6.96e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—kidney cancer	9.82e-06	6.94e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—kidney cancer	9.39e-06	6.63e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—kidney cancer	8.87e-06	6.27e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—kidney cancer	8.62e-06	6.09e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—kidney cancer	8.54e-06	6.03e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK3—kidney cancer	8.39e-06	5.93e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—kidney cancer	8.16e-06	5.77e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK1—kidney cancer	7.98e-06	5.64e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—kidney cancer	7.54e-06	5.33e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—kidney cancer	7.45e-06	5.26e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—kidney cancer	6.95e-06	4.91e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	6.93e-06	4.89e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—kidney cancer	6.7e-06	4.73e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—kidney cancer	5.25e-06	3.71e-05	CbGpPWpGaD
